Impact on the budget of ONLS program of vedolizumab introduction for the treatment of inflammatory bowel disease

• Główni autorzy: S. K. Zyryanov (Autor), I. N. Dyakov (Autor), A. V. Veselov (Autor), V. N. Kashnikov (Autor)
• Format: Książka
• Wydane: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Aim. Evaluation of the impact on the budget of the program for the provision of necessary medications (ONLS program) for the inclusion of a new drug vedolizumab for the treatment of adult patients with moderate or severe active ulcerative colitis (UC) and moderate or severe active Crohn's disea...